FDA OKs improved anaesthesia monitor:
This article was originally published in Clinica
Executive Summary
The US FDA has cleared for sale an easier-to-use version of Physiometrix' system for monitoring a patient's level of consciousness under anaesthesia. The new PSA 4000 monitor can now be used with the company's "frontal array" sensor - a disposable device that fits on the forehead of the patient being monitored. The clearance is expected to eliminate a considerable impediment to greater market acceptance of the PSA system, said John Williams, the North Billerica, Massachusetts firm's president and CEO. The company said it anticipated launching the product through its exclusive distribution partner, Baxter Healthcare, this month.
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.